1. Rapamycin inhibited the function of lung CSCs via SOX2
   Li-Xia Xie et al, 2016, Tumor Biol. CrossRef
2. Renal Cancer Stem Cells: Characterization and Targeted Therapies
   Anna Julie Peired et al, 2016, Stem Cells International CrossRef
3. Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells
   Zhi-xiang Yuan et al, 2016, Front. Pharmacol. CrossRef
4. CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma
   Susan Ling Ling Hoe et al, 2017, Sci Rep CrossRef
5. Advances in cancer stem cell targeting: How to strike the evil at its root
   Brigitte M. Pützer et al, 2017, Advanced Drug Delivery Reviews CrossRef
6. Tumor microenvironment – Unknown niche with powerful therapeutic potential
   Tomasz Kolenda et al, 2018, Reports of Practical Oncology & Radiotherapy CrossRef
7. Targeting mTOR as a Therapeutic Approach in Medulloblastoma
   Juncal Aldaregia et al, 2018, IJMS CrossRef
8. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis
   Stephan Marquardt et al, 2018, Seminars in Cancer Biology CrossRef
9. PI3K-PKB-mTOR hyperactivation in relation to nasopharyngeal carcinoma progression and prognosis
   Jian-Hua Yu et al, 2018, J Cell Biochem CrossRef
10. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
    Guangya Zhang et al, 2019, Cell Death Dis CrossRef
11. Targeted disruption of TORC1 retards young squab growth by inhibiting the synthesis of crop milk protein in breeding pigeon (Columba livia)
    M J Chen et al, 2019 CrossRef
12. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2
    Stephen B. Keysar et al, 2017, JNCI J Natl Cancer Inst CrossRef
13. null
    Amritha Suresh et al, 2017 CrossRef
14. Targeting Cancer Stem Cells with Small Molecules
    Sebastian Müller et al, 2017, Isr. J. Chem. CrossRef
15. null
    Alexandra E. Oklejas et al, 2020 CrossRef
16. Targeting cancer stem cell pathways for cancer therapy.
    Liqun Yang et al, 2020, Signal Transduct Target Ther CrossRef
17. Role of cancer stem cells in the development of giant cell tumor of bone
    Abdul Rouf War et al, 2020, Cancer Cell Int CrossRef
18. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway
    Wei Hu et al, 2016, Oncotarget CrossRef
19. The combination of NVP‑BEZ235 and rapamycin regulates nasopharyngeal carcinoma cell viability and apoptosis via the PI3K/AKT/mTOR pathway
    Hui Luo et al, 2018, Exp Ther Med CrossRef
20. Targeting Strategies for Renal Cancer Stem Cell Therapy
    Pengchao Fang et al, 2020, CPD CrossRef
21. Expression and roles of system L amino acid transporters in human embryonal carcinoma cells
    Kasit Chatsirisupachai et al, 2020, Andrologia CrossRef
22. Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma
    Sakibul Huq et al, 2020, Mol Cancer Ther CrossRef
23. Histone demethylase KDM4A plays an oncogenic role in nasopharyngeal carcinoma by promoting cell migration and invasion
    Jingyi Zhao et al, 2021, Exp Mol Med CrossRef
24. Epstein-Barr Virus LMP1-Activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties
    Nannan Zhu et al, 2022, J Virol CrossRef
25. PI3K/Akt/mTOR Signaling Pathway in Cancer Stem Cells
    Mohsen Karami Fath et al, 2022, Pathology - Research and Practice CrossRef
26. null
    Said M. Afify et al, 2022 CrossRef
27. Cancer stem cells: Signaling pathways and therapeutic targeting
    Joyeeta Talukdar et al, 2023, MedComm – Oncology CrossRef
28. Polyploidy and mTOR signaling: a possible molecular link
    Debopriya Choudhury et al, 2024, Cell Commun Signal CrossRef
29. Resveratrol: Targeting Cancer Stem Cells and ncRNAs to Overcome Cancer Drug Resistance
    Leila Rezakhani et al, 2024, CMM CrossRef